Forte Biosciences (FBRX) Capital Expenditures (QoQ) (2016 - 2025)
Forte Biosciences (FBRX) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 96.77% |
| Mar 31, 2024 | -64.71% |
| Dec 31, 2023 | -58.54% |
| Dec 31, 2019 | 147.22% |
| Sep 30, 2019 | 227.27% |
| Jun 30, 2019 | -57.69% |
| Mar 31, 2019 | 107.93% |
| Dec 31, 2018 | 11.59% |
| Sep 30, 2018 | -144.59% |
| Jun 30, 2018 | 1,748.89% |
| Mar 31, 2018 | -90.89% |
| Dec 31, 2017 | 850.00% |
| Sep 30, 2017 | -36.59% |
| Jun 30, 2017 | 203.70% |
| Mar 31, 2017 | 170.00% |
| Dec 31, 2016 | -93.75% |
| Sep 30, 2016 | -49.04% |
| Jun 30, 2016 | 665.85% |